Trial
NCT02465138
A Randomized Controlled Trial of IV Ketorolac to Prevent Post-ERCP Pancreatitis
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of California, San Francisco
Collaborators
—
Condition
Pancreatitis
Intervention
Ketorolac
Why stopped
Lack of Funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-04-28